"Acute Stroke Treatment Trials: A New Era of Regulatory, Technology and Design Opportunities"

STAIR V Sponsors

Amkor Pharma


Axaron Bioscience

AG Bayer HealthCare

BeneChill, Inc.

Biotechnology Fund

Biotrofix, Inc.


Boston Life Sciences

CoAxia, Inc.

Concentric Medical, Inc.

Cordis Corporation

Daiichi Asubio Pharmaceuticals, Inc. Daiichi Medical Research

EBEWE Pharma

EKOS Corporation

enERGetics Ferrer

Group FibroGen, Inc.

Forest Laboratories

Genentech, Inc.


Halozyme Therapeutics, Inc.

HBK Investments L.P.

ImaRx Therapeutics, Inc.

K.L. Keim Consultancy Group, LLC

J.P. Morgan

Merck & Co.

Mitsubishi Pharma America, Inc. Mitsubishi Pharma Corporation Neurobiological Technologies, Inc. Nordmark Araneimittel

Novo Nordisk A/S

OmniSonics Medical Technologies

Ortaco, Inc.


Penumbra, Inc.

Pfizer, Inc.

PhotoThera, Inc.

Renovis, Inc.

Rodman & Renshaw LLC

Serono International

ThromboGenics Ltd

Wyeth Research

Xigen S.A. 

The information contained in this website reflects opinions of STAIR participants regarding the process of conducting research and development into existing, new and prospective drugs and devices for the treatment of stroke. The information is not intended to be a substitute for rigorous independent testing and development of individual compounds and devices by research sponsors, nor should the information and opinions be construed as official government regulations or official interpretations of government regulations. All government regulations and their applications to specific research studies and clinical trials are subject to individual deliberations between study sponsors and government agencies. The information contained in this website is not intended to be a substitute for sound medical advice, clinical judgment or informed treatment decisions.

STAIR® is a Registered Trademark of The Stroke Group.   

© 2020 The Stroke Group